Syringomyelia is a disorder in which fluid-filled cyst forms within the spinal cord. The fluid-filled cyst called as the syrinx, and get bigger and elongate over time by damaging the spinal cord and compressing the nerve fibers that carry information to the brain and from the brain to the rest of the body.

A number of factors such as rising need for the better treatment methods, increasing prevalence of syringomyelia, and related complications, increasing government assistance, improving regulatory framework, increasing awareness, and rising funding and reimbursement are propelling the growth of the global [URL=https://www.marketresearchfuture.com/reports/syringomyelia-market-5240/]syringomyelia market[/URL] .

However, challenges in the research and development, higher treatment cost, injuries occur because of treatment, and poor healthcare system in low and middle-income countries may hamper the growth of the market over the given period.

The global syringomyelia market is expected to grow at a CAGR of 7.0% during the forecast period 2017-2023.

Segmentation

The global syringomyelia market is segmented on the basis of type, diagnosis, treatment, and end user.

On the basis of the type, the market is classified as congenital syringomyelia (communicating syringomyelia) and acquired syringomyelia (noncommunicating syringomyelia).

On the basis of the diagnosis, the market is classified as magnetic resonance imaging (MRI), computerized tomography (CT) scan, and others.

On the basis of the treatment, the market is classified as monitoring, surgical care, and medication. The surgical care is further segmented into Chiari surgery, expansive duraplasty, surgical removal of the obstruction, draining the syrinx (shunt operation), and others. The medication is further segmented into analgesics, muscle relaxants, and others.

On the basis of the end user, the market is segmented into hospitals, clinics, diagnostic centers, drug stores, pharmacies, and others.

Key Players

Some of key the players in the global syringomyelia market are Stryker, Medtronic Plc, Boston Scientific Corporation, B. Braun Melsungen AG, Johnson & Johnson Private Limited, CONMED Corporation, Novartis AG, Smith & Nephew PLC, Zimmer Holdings Inc., TransEnterix, Inc., Becton, Dickinson and Company, Aspen Surgical Products, Inc., Olympus Corp., Richard Wolf GmbH, Siemens Ltd., STORZ MEDICAL AG, and others.

Browse Full Report @ [URL=https://www.marketresearchfuture.com/reports/syringomyelia-market-5240]Click Here[/URL]